Invention Grant
- Patent Title: Substituted morpholine derivatives having activity against pain
-
Application No.: US15769520Application Date: 2016-10-21
-
Publication No.: US10421750B2Publication Date: 2019-09-24
- Inventor: Marina Virgili-Bernado , Carlos Alegret-Molina
- Applicant: ESTEVE PHARMACEUTICALS, S.A.
- Applicant Address: ES Barcelona
- Assignee: ESTEVE PHARMACEUTICALS, S.A.
- Current Assignee: ESTEVE PHARMACEUTICALS, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Hueschen and Sage
- Priority: EP15382524 20151023
- International Application: PCT/EP2016/001743 WO 20161021
- International Announcement: WO2017/067665 WO 20170427
- Main IPC: C07D413/04
- IPC: C07D413/04 ; A61P29/00
Abstract:
The present invention relates to substituted morpholine derivatives having pharmacological activity towards the sigma (σ) receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.
Public/Granted literature
- US20180305343A1 SUBSTITUTED MORPHOLINE DERIVATIVES HAVING ACTIVITY AGAINST PAIN Public/Granted day:2018-10-25
Information query
